Nelly Etienne-Selloum

7PUBLICATIONS
19CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 11, 2023
Blocking EREG/GPX4 Sensitizes Head and Neck Cancer to Cetuximab through Ferroptosis Induction.

Aude Jehl, Ombline Conrad, Mickaël Burgy

|Oct 27, 2022
Bioimaging Nucleic-Acid Aptamers with Different Specificities in Human Glioblastoma Tissues Highlights Tumoral Heterogeneity.

Elisabete Cruz Da Silva, Sophie Foppolo, Benoît Lhermitte

|Jan 21, 2022
Temozolomide-Acquired Resistance Is Associated with Modulation of the Integrin Repertoire in Glioblastoma, Impact of α5β1 Integrin.

Saidu Sani, Nikita Pallaoro, Mélissa Messe

|Sep 28, 2021
Expression Analysis of α5 Integrin Subunit Reveals Its Upregulation as a Negative Prognostic Biomarker for Glioblastoma.

Nelly Etienne-Selloum, Julien Prades, Diana Bello-Roufai

|Jul 02, 2021
Cav1/EREG/YAP Axis in the Treatment Resistance of Cav1-Expressing Head and Neck Squamous Cell Carcinoma.

Mickaël Burgy, Aude Jehl, Ombline Conrad

|Apr 30, 2021
A Systematic Review of Glioblastoma-Targeted Therapies in Phases II, III, IV Clinical Trials.

Elisabete Cruz Da Silva, Marie-Cécile Mercier, Nelly Etienne-Selloum

Pageof 2

Frequent Collaborators

6 joint publications

Monique Dontenwill

4 joint publications

Sophie Foppolo

4 joint publications

Sophie Martin

3 joint publications

Laurence Choulier